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Background: Brucellosis is a worldwide disease of mammals caused by Alphaproteobacteria in the genus Brucella.
The genus is genetically monomorphic, requiring extensive genotyping to differentiate isolates. We utilized two
different genotyping strategies to characterize isolates. First, we developed a microarray-based assay based on 1000
single nucleotide polymorphisms (SNPs) that were identified from whole genome comparisons of two B. abortus
isolates, one B. melitensis, and one B. suis. We then genotyped a diverse collection of 85 Brucella strains at these SNP
loci and generated a phylogenetic tree of relationships. Second, we developed a selective primer-extension assay
system using capillary electrophoresis that targeted 17 high value SNPs across 8 major branches of the phylogeny
and determined their genotypes in a large collection (n= 340) of diverse isolates.
Results: Our 1000 SNP microarray readily distinguished B. abortus, B. melitensis, and B. suis, differentiating B.
melitensis and B. suis into two clades each. Brucella abortus was divided into four major clades. Our capillary-based
SNP genotyping confirmed all major branches from the microarray assay and assigned all samples to defined
lineages. Isolates from these lineages and closely related isolates, among the most commonly encountered lineages
worldwide, can now be quickly and easily identified and genetically characterized.
Conclusions: We have identified clade-specific SNPs in Brucella that can be used for rapid assignment into major
groups below the species level in the three main Brucella species. Our assays represent SNP genotyping approaches
that can reliably determine the evolutionary relationships of bacterial isolates without the need for whole genome
sequencing of all isolates.Background
Brucella are Gram-negative bacteria and the causative
agent of brucellosis in domesticated animals, wildlife,
and humans. Although the bacteria exhibit relatively
strong host preference, separating the various Brucella
species has proven extremely difficult due to minimal
genetic differentiation [1]. Based on DNA-DNA
hybridization, brucellae have previously been proposed
to comprise a single species, with a series of biovars [2].
However, phylogenetic approaches explicitly incorporat-
ing host preference and virulence have upheld the six
classical Brucella species: B. abortus (bovine), B. meliten-
sis (caprine and ovine), B. suis (porcine), B. canis* Correspondence: jeff.foster@nau.edu
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reproduction in any medium, provided the or(canine), B. neotomae (desert woodrat), and B. ovis
(ovine) [3-5]. Several new species have been recently
described, including at least two species in marine mam-
mals (B. ceti in dolphins, porpoises, and whales and B.
pinnipedialis in seals) [6] and an additional species B.
microti in the common vole (Microtus arvalis) [7]. Other
Brucella species undoubtedly exist within known and
novel hosts [8-11].
The limited genetic differentiation and conservation
within Brucella genomes has made genotyping a chal-
lenge. A promising approach that is capable of being
incorporated into high-throughput assays is the use of
single nucleotide polymorphisms (SNPs). Comparisons
of Brucella genomes have revealed hundreds of SNPs
that distinguish various strains [12-14]. Although the era
of Next-Generation sequencing [reviewed in 15] is rap-
idly increasing available data for microbial genomictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cost effective for genotyping large numbers of isolates
and requires intensive bioinformatic efforts. Further-
more, in low diversity organisms such as Brucella only a
small fraction of the nucleotides are polymorphic, sug-
gesting that once rare polymorphisms are discovered,
methods other than whole genome sequencing are more
efficient for most purposes.
Molecular Inversion Probe (MIP) assays are an effi-
cient and relatively inexpensive method of interrogating
thousands of SNPs in large numbers of samples [16]. Al-
though typically applied to research on human disease,
the MIP assay can be readily applied to genotype SNPs
in bacterial genomes. We compared four genomes from
B. abortus, B. melitensis, and B. suis to discover SNPs.
We created a MIP assay to genotype 85 diverse samples
and to discover canonical SNPs [17] that define Brucella
species, strains, or isolates. We then created SNP-
specific assays that use a Capillary electrophoresis
Universal-tailed Mismatch Amplification mutation assay
(CUMA) approach for major branch points in the phyl-
ogeny and screened them against a large and diverse col-
lection of isolates (n= 340). Finally, we compared these
results to 28 Brucella whole genomes in silico to place
our genotyping into context with all major biovars and
isolates.
Results
A total of 833 MIP probes consistently amplified their
target sites across 85 samples. Among these probes, 777
identified truly polymorphic sites. This dataset contained
only 4% missing data (2,636 no calls in 66,045 SNPs),
where no SNP was determined at a particular locus for a
sample. Comparisons to SNPs from 28 whole genomes
yielded 735 SNPs in our phylogenetic analysis (Figure 1),
allowing for placement of these genomes within the MIP
tree and in silico determination of their SNP alleles. The
full MIP tree with all 777 loci and 85 samples, excluding
the whole genomes in the comparisons, is also given
(Additional file 1: Figure S1).
Our MIP assay distinguished B. abortus, B. melitensis,
and B. suis; the three prominent Brucella species (Fig-
ure 1). A total of 524 SNP loci had complete allele calls
(i.e. no missing data) across all 85 samples. The assay
strongly differentiated B. melitensis and B. suis into two
clades each. Within B. melitensis, at least 27 SNPs on
branch H separate strain 16 M and its related isolates in
biovar 1 from isolate 63–9 and related isolates of biovars
2. Subsequent analyses (see below) group biovar 3 with
biovar 2 isolates. Based on these data, the assay for
branch H appears to be specific to B. melitensis biovar 1.
The two clades in B. suis, denoted by branches I and J,
included all isolates of in the species except for biovar 5,
which was distantly related to other members of thisspecies. Some isolates from B. suis are more closely
related to B. canis isolates (branch J) than to other B.
suis isolates (branch I), indicating that B. suis is a para-
phyletic species. Of the SNPs with complete genotyping
data, at least 31 SNPs on branch I separate B. suis 1330
and related isolates from B. canis and related B. canis
and B. suis isolates. However, no SNPs uniquely identi-
fied B. canis. Brucella abortus was even more differen-
tiated, and can be divided into at least four distinct
clades. Samples from B. abortus biovar 1, which contains
the two SNP discovery strains, plus the type strain for
biovar 2 (strain 86/8/59), make up the majority of sam-
ples and diversity within the B. abortus clade. All were
found on branch E, which was further divided into
branches A-D. Samples from the other B. abortus bio-
vars are more distantly related and form distinct
branches. As expected, the other species in the assay, in-
cluding B. neotomae, B. ceti, B. pinnipedialis, and B. ovis
were poorly distinguished from each other. Missing data
for SNP loci caused the differences in branch lengths
that are seen between Figure 1 and Figure S1.
CUMA assays verified the SNP alleles for all 85 of the
samples run in the MIP assay. In addition, the 17 SNPs
from the CUMA assays allowed for placement of a lar-
ger panel of 340 isolates within the MIP phylogeny
(Additional file 2: Table S3). Nine of these SNPs were
located on the same branch as another assay, or in one
instance the same branch as two other assays, so did not
provide any additional genotyping information. In the
final tally there were assays for eight branches of the
phylogeny, with assays specific to the following promin-
ent isolates/clades and related isolates: B. abortus 2308,
B. abortus 2308 + S19, B. melitensis 16 M, B. melitensis
biovar 1, and B. suis 1330. From our diverse isolate col-
lection we had the following distribution of calls for the
branches, with the most derived call taking precedence
over more ancestral calls: A = 1, B = 23, C = 8, D= 22,
E = 7, F = 0, G= 15, H = 91, I = 33, J = 17, no derived call
(all isolates not in species B. abortus, B. melitensis, or B.
suis/canis) = 25, no call for any assay = 7, ancestral within
B. abortus= 12, ancestral within B. melitensis= 68, ances-
tral within B. suis= 11.
Discussion
Our assays show clear distinctions within and among B.
abortus, B. melitensis, and B. suis. Our CUMA assays
targeted clade-specific SNPs that can be incorporated
into most other genotyping assays such as TaqMan Real-
time PCR for increased sensitivity [18,19]. We have
identified several important targets that should prove
useful for clinical, epidemiological, and forensic pur-
poses. For example, the assays targeting branches A, D,
and I are specific to isolates closely related to B. abortus
2308 and B. abortus 9–941, and B. suis 1330,
B. suis bv. 4 str. 40
B. suis bv. 1 str. 1330
B. suis bv. 2 str. Thomsen
 B. ovis str. 25840
B. neotomae str. 5K33
B. suis bv.5 str. 513
bv. 9 str. C68
bv. 6 str. 870
bv. 4 str. 292
 bv. 1 str. 9-941
bv. 3 str. Tulya
bv. 2 str. 86/8/59
 bv. 1 str. 2308
bv. 1 str. S19
bv. 3 str. Ether
 bv.1 str.16M
 bv.1 str. Rev1
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Figure 1 Brucella phylogeny based on comparison of 735 single nucleotide polymorphisms screened using Molecular Inversion Probes
(MIP) in 85 samples and then compared to those SNPs in 28 whole genome sequences, which are the named isolates in the tree.
Discovery genomes are indicated in red. Letters on branches refer to phylogenetic locations of CUMA assays developed in this work and
genotyped against DNA from a diverse collection of 340 isolates. Circled numbers indicate the number of isolates with identical MIP genotypes
(allelic profiles) at that branch location.
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branch and identify B. melitensis 16 M and closely
related isolates. Isolates from B. abortus 2308 and 9–
941, B. suis 1330, and B. melitensis 16 M are from com-
mon, genetically monomorphic clades of Brucella and
the SNP assays developed here are a reliable and useful
way of identifying these four common groups.
Branch E is particularly interesting in terms of Bru-
cella taxonomy. The clade that this branch defines
includes isolates from B. abortus biovars 1, 2, and 4. Po-
tential issues with biovar and phylogenetic correspond-
ence in B. abortus have been noted previously [20].
Upon closer evaluation of the whole genomes used in
our analyses, the apparent paraphyly within B. abortus
biovar 1, since isolates from biovar 2 are within the bio-
var 1 clade, does not hold true when all the genomes areincluded. However, CUMA assays indicate that at least
four isolates from other B. abortus biovars (3 of biovar
4, 1 of biovar 2) fall onto the B/C branch. This would
suggest that either biovar 1 is paraphyletic or there have
been issues with biovar determination.
SNP-based approaches also enable assessment of
errors in genome sequences. Whole genome compari-
sons of the region associated with SNP10621, which
were intended to target branch J in B. suis/B. canis, also
share a SNP allele with B. abortus 9–941. Taken at face
value, this would suggest homoplasy at this locus. Yet, in
our CUMA assays B. abortus 9–941 did not group with
B. suis, likely indicating sequencing error.
Finding nucleotide polymorphisms that differentiate
clades, species, or isolates is dependent on the genomes
used for SNP discovery. In general, one will only find
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in the comparisons and novel SNPs will remain undis-
covered [21]. This discovery bias can strongly affect
taxonomic interpretation of results [22,23]. Although
discovery bias is often less consequential for genotyping
efforts, the effects of our choice of strains for SNP dis-
covery are clearly apparent in our phylogenetic tree. The
discovery strains are distinguished by their positions at
terminal branches in the phylogeny. There is greater di-
versity observed in B. abortus simply because two strains
were part of the discovery panel. Furthermore, although
isolates on a branch will be grouped by the SNPs they
share (or do not share), additional structure exists in the
“true” phylogeny that is not apparent in the genotype
tree. Branch lengths are also highly affected by the SNP
discovery process. Species that are basal within this phyl-
ogeny, such as B. ceti, B. pinnipedialis, B. ovis, and B.
neotomae have short branch lengths merely because
these genomes were not part of SNP discovery. It must
also be noted that B. suis biovar 5 is part of this basal
group. SNPs that should group it with the rest of the B.
suis clade were not present in our MIP assay, which is
not surprising since this branch is extremely short, even
with whole genome analysis [JTF unpubl. data, [24]. We
did not observe differentiation of these and the other
Brucella species, nor did we expect it because genomes
from these groups were not a part of SNP discovery.
Whole genome resequencing at the Broad Institute of
MIT/Harvard recently generated genomes for over 100
additional Brucella strains and these genomes should
provide a broad basis for future genotyping efforts, with
canonical SNPs developed for each of the important iso-
lates and clades. Future genotyping efforts should in-
clude SNPs from all of the recognized species and
biovars. Comparative work using some of these genomes
has already been fruitful, demonstrating the emergence
of the marine Brucella from within the terrestrial Bru-
cella and showing a methodology for whole genome
analysis [24].
A trade-off exists in current genotyping efforts be-
tween throughput and genomic sampling. Does one aim
for a maximum amount of potentially informative loci
through approaches such as whole genome sequencing
but having to sacrifice the number of isolates that can be
evaluated? Or does one aim for more complete sampling
of large numbers of isolates but with a limited set of loci
using individual SNP assays such as CUMA? Of course
the ultimate answer depends on your research interest
or clinical application as well as the amount of resources
at hand. MIP assays provide phylogenetic resolution for
an intermediate number of samples and intermediate
number of SNPs. Nonetheless, MIP assays, or any assays
based on previously discovered SNPs, will always have
their inference limited by the genomes used in SNPdiscovery [21]. MIP assays do however allow for a focus
on resolving branches of specific interest. Data from
these assays then allows for targeted down selection of
loci so that focal branches and isolates on them can be
thoroughly interrogated using individual SNP assays.
Identifying canonical SNPs and verifying their ability to
differentiate clades by screening large numbers of iso-
lates is the essential part of genotyping [17]. Less im-
portant is the type of assay used for SNP differentiation
because it is highly dependent on the numbers of SNPs
and samples one wants to screen. The MIP and CUMA
SNP screening techniques are just two of many methods
that can be used for SNP genotyping in Brucella and
other bacteria.Conclusions
We developed and evaluated two different SNP-based
genotyping systems for three well studied species of Bru-
cella: B. abortus, B. melitensis, and B. suis. The first
genotyping approach, using Molecular Inversion Probes,
divided the species into its three respective groups and
allowed for finer scale genetic resolution. Notably, this
resolution occurred almost entirely within the lineages
of the four strains that were used for SNP discovery: B.
abortus 2308, B. abortus 9–941, B. melitensis 16 M, and
B. suis 1330. This is to be expected since the choice of
genomes for SNP discovery has a pervasive effect on the
phylogenetic patterns that can be determined. We fol-
lowed the MIP assay with development of Capillary elec-
trophoresis Universal-tailed Mismatch Amplification
mutation assays that targeted major branch points in the
MIP phylogeny. We then genotyped a large and diverse
collection of isolates. The main result is the develop-
ment of fine scale genotyping assays that target among
the most important and widespread lineages of Brucella.
Moreover, these and closely related isolates can be easily
and quickly distinguished from all other Brucella
isolates.
Despite the era of whole genome sequencing being
upon us, SNP-based genotyping and other targeted
assays will remain relevant. Sequencing technology is ad-
vancing rapidly and costs per genome are quickly dimin-
ishing such that whole genome genotyping is the future
of phylogenetics, forensics, and diagnostics. In fact,
whole genome genotyping will soon be cost competitive
with most other genotyping strategies and will have the
advantage of capturing nearly all of the genetic variation
with no issues of discovery bias. Nonetheless, targeted
assays will remain a viable option for such goals as rap-
idly and easily characterizing large strain collections,
clinical samples, and samples containing only trace
amounts of DNA. Concerted efforts must be made to in-
corporate data from earlier genotyping strategies into
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is not lost in the rush to sequence everything.
Methods
SNP selection
SNPs were selected by comparisons of the four Brucella
genomes that were available at the time of MIP develop-
ment: B. melitensis 16 M [25], B. suis 1330 [13], B. abor-
tus 2308 [26] and B. abortus 9–941 [12]. SNPs from the
whole genome sequences were discovered using an in-
house pipeline that performs pairwise comparisons of
200 base regions around each SNP using MUMMER
[see [14]. Determining the quality of the putative SNPs
is essential because only high quality sequence data
should be used for developing genotyping analyses [27].
Quality measures included the number of bases between
SNPs and the number of bases that are conserved on
each side of a SNP within a specified region. To reduce
the potential effects of sequencing error, we then incor-
porated sequencing quality scores from Phred values.
We selected only those putative SNPs with quality scores
≥30, average quality scores of SNP flanking regions (30
base pairs) ≥ 30, and where each base in the flanking
regions had a quality score ≥ 20. Perl and Java scripts
were then employed for additional alignments and to
compile and summarize the data. Using this process,
1000 putative SNPs were selected for interrogation by
the MIP chip. SNP locations and flanking regions of 40
bases on each side were sent to the manufacturer for
assay design (Affymetrix, Santa Clara, CA).
MIP primers and probes
The MIP workflow is relatively straightforward: 1) SNPs
are first discovered using comparisons of whole genomes
or particular regions of interest within sequenced gen-
omes; 2) a series of assays are created with primers tar-
geting each SNP; 3) amplification products are
generated in a single multiplexed PCR; 4) amplicons
specific to each SNP for each sample are hybridized to a
universal tag microarray; 5) each SNP is fluorescently la-
beled based on the corresponding nucleotide of the sam-
ple and is then visualized on the microarray.
Primers and probes were designed for a GeneChip
Custom 5 K SNP Kit (Affymetrix), which is one of the
available forms of the MIP assay. In this assay, all 1000
SNPs were assessed in a single multiplex reaction for
each sample. Assays containing ~3000 Francisella tular-
ensis SNPs [28] and ~1000 Burkholderia pseudomallei
SNPs (Keim unpubl. data) were run concurrently on the
same chip, which reduced the cost of the assays for each
group. MIP technology involves a specific probe that
binds to flanking sequence surrounding a SNP site. Due
to the orientation of the oligonucleotide sequence, the
probe anneals as an inverted loop and a single base gapis created at the SNP site. The base at the SNP site is
then added in one of four reactions involving unlabeled
nucleotides. After ligation and exonuclease steps, the
probe released from the sequence is amplified with PCR
using universal primers specific for a portion of all
probes. Only those probes where the SNP base has been
added are successfully amplified. For a full description of
the MIP methodology, see Hardenbol et al. [16]. Typic-
ally, approximately 80% of the MIP probes that are
designed pass quality control and assurance standards at
Affymetrix. Consistent with this standard, 833 of the
1000 probes (83.3%) amplified in our panel of 85 Bru-
cella isolates for at least 80% of SNP alleles at a locus.
Among these SNPs, 56 were monomorphic, leaving a
final set of 777 phylogenetically informative loci. This
dataset contained only 4% missing data, which were
given an allele of N in phylogenetic analyses. To allow
this dataset to be directly comparable to SNPs from
whole genome analyses, we then did an in silico com-
parison of 28 whole genome sequences of Brucella from
GenBank (Additional file 3: Table S1). Not all of the
SNPs in the final set were present in all genomes or had
likely duplication events so were removed from the ana-
lysis, resulting in 735 SNPs for phylogenetic analysis.
DNA samples
We ran 85 Brucella DNA samples on the MIP assay
from a diverse isolate collection that included B. abortus
(33), B. melitensis (30), B. suis (11), B. canis (6), B. neoto-
mae (1), B. ovis (1), B. ceti (1), and B. pinnipedialis (2).
The 85 samples tested are indicated (Additional file 4:
Table S2). We focused our sampling on the first three
species because SNP discovery had been conducted with
the genomes of only these species and thus differenti-
ation would be restricted primarily to these species
[21,22]. Samples were analyzed at a range of concentra-
tions, from 0.6 - 20 ng/μl. Our larger panel of isolates
(n= 340), used only in the CUMA assays (detailed
below), is from a portion of our DNA collection, which
came from a variety of sources (Additional file 4: Table
S2). DNA was extracted using several different methods
including chloroform, kit-based, and heat soak DNA
extractions, although the extraction method was not al-
ways known for each sample. Isolates were largely re-
cent, coming from sampling in the past 15 years. We
note that the majority of samples came from the United
States so this collection does not represent a truly global
sampling.
Phylogenetics and CUMA assays
We created a matrix of SNP alleles for all SNP positions
and formatted the data as one concatenated sequence
for each sample. We analyzed this sequence in PAUP*
using a heuristic search with the maximum parsimony
Table 1 Capillary electrophoresis Universal-tailed Mismatch Amplification mutation assays for genotyping single nucleotide polymorphisms in Brucella isolates
SNP
assay








2366 CACGGCCTATCTGCTGGGCT CACGGCCTATCTGCTGGGAC GAGCGTCGTGAAGTCGGTTAC 151 NED/
PET
T/C 1173417 A
4748 ACAGTCAGACAAGGACCGGA AACAGTCAGACAAGGACCGAC GTAACAAGAACACGGCCTTTACGC 155 FAM/
VIC
C/A 1744207 B
1562 CACGCAAAATAGCTAAATGAAATATAC ACGCAAAATAGCTAAATGAAATATTG GATGGCTTTCCGGGGCTATC 189 NED/
PET
C/G 1405281 B
2922 TAAAGACGGCGATTACCGAG GTAAAGACGGCGATTACCGTA GACAACGCCAACGGCATTCTT 179-180 NED/
PET
G/A 413931 C
991 CAGTATGAAGCTTATTTTAAGCCA GCAGTATGAAGCTTATTTTAAGCAG GTATGCTCAAGCGCCAAGCTG 195 FAM/
VIC
G/A 1601481 C
3740 CGGAATACGAAAACTCACATTATAG CGGAATACGAAAACTCACATTATTA GCGGGGCCATAGGGAAATAC 133 VIC/
FAM
G/A 675905 D
1344 ACACGGTTGGAATTATCCACT ACACGGTTGGAATTATCCATC GACCGGCAAGCTTGAATCG 171 FAM/
VIC
C/T 1392400 D
5754 GCTGGAACATATAGAAAAGATCATAAAAG GCTGGAACATATAGAAAAGATCATAAATA GCAGCCTTCCAAGGAAAAGAACG 117 VIC/
FAM
G/A 1083478 E
1522 GGTGAACATTTCGCCATCAG GGTGAACATTTCGCCATCTA GTTCGATGAACCTCGTGGCATT 123-124 NED/
PET
G/A 497534 E
6214 ATTGAATGATGAGCGATATTGTG TGAATGATGAGCGATATTGCA GAGCGCTTGTCGGAGGTTGTT 110-112 PET/
NED
A/G 242224 F
2995 CGAAACAGCTGAGAAGATCGAG AAACAGCTGAGAAGATCGGC GTTAGAAGCCTGGCCCGTTCTC 101 VIC/
FAM
G/C 478183 G
8872 GCATCGAACTCATTCTCGCT GCATCGAACTCATTCTCGTC GCGAAATCAAGGCCCCATTTG 160 PET/
NED
C/T 1170581 G
1688 CGATCTGCCAGTTGACGAGA CGATCTGCCAGTTGACGATT GTGCAACGCCTCACGCATAAT 181 FAM/
VIC
T/A 1348434 H
5362 ATTACCACGCACCGATGAGA ATTACCACGCACCGATGAAG GCATCCATGACGGCGTGAAAC 240 FAM/
VIC
G/A 507275 I
8306 CACGGTTGCATGGTTTGTATATA ACGGTTGCATGGTTTGTATAAG GAGCACCAAACCGGGTGATGT 259 FAM/
VIC
G/A 1876820 I
10621 TATGCAATTCGTGTCGCATG TATGCAATTCGTGTCGCAGA GTTTCAGGACTTTTGGGAACTGACC 233 NED/
PET
G/A 1207543 J
10621R GGTAATTTTTCCGCTTGCGT CGGTAATTTTTCCGCTTGCTC GCACGGGCGCAGGCTCTTAT 250 PET/
NED
C/T 1207539 J
First allele is the ancestral SNP state and has a VIC or NED dye; second allele is derived and has a FAM or PET dye. Universal tails were added to the 5' end of the allelic primers during primer synthesis. See Figures 1
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swapping [29]. We rooted the phylogeny with Brucella
sp. 83/13 because of its basal position in the Brucella
phylogeny for the isolates in our screening panel
(unpubl. data). The 83/13 isolate came from an Austra-
lian rodent and data suggest that it is related to the trad-
itional Brucella spp. [30] but likely diverged from the
main/core Brucella. Using the phylogeny developed from
the MIP assay to determine groups, we employed clade-
specific SNPs using CUMA [31], following mismatch
amplification concepts [32,33]. Briefly, the CUMA assay
exploits mismatch amplification differences during PCR
amplification that generate different length fragments
that are allele (i.e. SNP) specific. The amplification pri-
mers have unique tails that can subsequently bind to
fluorescently labeled universal-tailed primers. These
unique tails are added to the 5' end of the allelic primers
during primer synthesis. We used the following
sequences and dyes for the universal tails: VIC-
acacgcacttgacttgtcttc, FAM6-acccaactgaatagagagc, PET-
ctgtccttacctcaatctc, NED-atcgactgtgttaggtcac. Assays
were based on a range of amplicon sizes without overlap
(range 101–259 bp) and two different dye combinations
were used to visualize the fragments that discriminated
each SNP state (VIC/FAM, NED/PET) (Table 1). We ran
10 mL reactions in either singleplex or multiplex with
the following mastermix: 1X PCR buffer, 2 mM MgCl2,
0.2 mM dNTPs (Invitrogen, Carlsbad, CA), 0.2 U iTaq
DNA Polymerase (Bio-Rad, Hercules, CA), and molecu-
lar grade water (GIBCO, Carlsbad, CA). Reactions were
multiplexed in two different PCR reactions and frag-
ments were run in a single capillary injection on an ABI
3100 Genetic Analyzer (Applied Biosystems, Foster City,
CA). Thermocycler conditions were as follows: hot start
of 95°C for 5 min, followed by 40 cycles of 30 s at 95°C,
30 s at 60°C and 30 s at 72°C, with a final extension at
72°C for 5 min. Melting temperatures for the primers
ranged from 57.1 to 67.0°C (mean 61.7°C).
SNPs used in the CUMA were randomly selected from
the various options available on each branch, with fewer
options possible with shorter branches. If development
of the assay failed to produce effective primer pairs
based on standard primer design parameters we simply
selected a new SNP locus. Using the CUMA assays, we
genotyped a diverse set of isolates (n= 340), which
included all recognized biovars and type strains (except
B. microti and B. suis biovars 3 and 5), against 17 SNP
assays for 10 branches. For each sample we determined
if the SNP allele for each locus was ancestral or derived
on the corresponding branch and then verified where
the sample was placed on the tree. When possible, we
selected two SNPs from each of the major branches. We
generated amplicons for the SNP regions in four PCR
reactions for each of the two multiplex PCRs and thenpooled the PCR product in one capillary injection. If the
CUMA assay failed any locus in multiplex reactions, we
reran that locus in singleplex, which generally allowed
for determination of the SNP allele. Samples with single-
plex failure largely appeared to be of poor DNA quality
since there were typically failures across several different
CUMA assays (Additional file 4: Table S2).Additional files
Additional file 1: Figure S1. Brucella phylogeny using maximum
parsimony developed using 777 single nucleotide polymorphisms.
Letters on branches refer to phylogenetic locations of CUMA assays
developed in this work. Stars on branches represent phylogenetic
locations of species or clade specific assays from Foster et al. 2008. In this
figure we rooted with B. neotomae because it is the most basal taxon in
the Brucella phylogeny for these taxa tested (unpubl. data).
Additional file 2: Table S3. List of Brucella DNA samples tested
with CUMA. DNA samples came from the following institutions,
Louisiana State University (LSU), California Department of Health Services
(CDHS), U.S. Armed Forces Institute of Pathology (AFIP), Alaska Public
Health Laboratory (APHL), Brigham Young University (BYU), U.S. Centers
for Disease Control (CDC), USDA-National Animal Disease Center (NADC),
and the Arizona Department of Health Services (ADHS). Samples with a
species name in the branch column were genotyped as that species
using assays in (Foster et al. 2008) but gave all ancestral SNP alleles in our
assays. Assays for B. abortus in blue B. melitensis in pink, and B. suis/canis
in green, which correspond to the branches in Figure 1. The 85 samples
also run in the MIP assay have an asterisk, except for 3 samples not run
on CUMA. Samples likely mislabeled, due to incorrect branch assignment
based on species/biovar, are highlighted in yellow.
Additional file 3: Table S1. List of 28 whole genomes used for in
silico comparisons to SNP alleles from MIP assay.
Additional file 4: Table S2. List of Brucella isolates used in 17
CUMA assays, including isolate name, species, and biovar when
known or applicable and the SNP allele for each assay.
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